Insider Trading Alert - MOS, VVUS, XRAY, PSX And IVZ Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 12, 2013, 237 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $100.00 to $356,344,136.36.

Highlighted Stocks Traded by Insiders:

Mosaic (MOS) - FREE Research Report

Ebel Gregory L who is Director at Mosaic bought 1,630 shares at $47.89 on Nov. 12, 2013. Following this transaction, the Director owned 1,630 shares meaning that the stake was reduced by 100% with the 1,630 share transaction.

Koenig Emery N. who is Director at Mosaic bought 2,200 shares at $47.19 on Nov. 12, 2013. Following this transaction, the Director owned 5,891 shares meaning that the stake was reduced by 59.6% with the 2,200 share transaction.

The shares most recently traded at $48.15, up $0.96, or 2% since the insider transaction.

The average volume for Mosaic has been 5.3 million shares per day over the past 30 days. Shares are down 15.01% year to date as of the close of trading on Tuesday.

The Mosaic Company produces and markets concentrated phosphate and potash crop nutrients for the agriculture industry worldwide. It operates in two segments, Phosphates and Potash. The stock currently has a dividend yield of 2.08%. The company has a P/E ratio of 13.6. Currently there are 8 analysts that rate Mosaic a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MOS - FREE

TheStreet Quant Ratings rates Mosaic as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, weak operating cash flow and a generally disappointing performance in the stock itself. Get the full Mosaic Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Vivus (VVUS) - FREE Research Report

Denner Alexander J who is Director at Vivus bought 566,844 shares at $8.59 on Nov. 12, 2013. Following this transaction, the Director owned 2.6 million shares meaning that the stake was reduced by 28.24% with the 566,844 share transaction.

The shares most recently traded at $9.38, up $0.79, or 8.44% since the insider transaction. Historical insider transactions for Vivus go as follows:

  • 12-Week # shares bought: 10,000
  • 24-Week # shares bought: 25,000

The average volume for Vivus has been 2.6 million shares per day over the past 30 days. Vivus has a market cap of $924.5 million and is part of the health care sector and drugs industry. Shares are down 32.27% year to date as of the close of trading on Tuesday.

VIVUS, Inc., a biopharmaceutical company, engages in developing and commercializing therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health. Currently there are 3 analysts that rate Vivus a buy, 3 analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VVUS - FREE

TheStreet Quant Ratings rates Vivus as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity, generally disappointing historical performance in the stock itself and generally high debt management risk. Get the full Vivus Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

DENTSPLY International (XRAY) - FREE Research Report

Jones Leslie A who is Director at DENTSPLY International sold 4,000 shares at $47.68 on Nov. 12, 2013. Following this transaction, the Director owned 97,892 shares meaning that the stake was reduced by 3.93% with the 4,000 share transaction.

The shares most recently traded at $47.80, up $0.12, or 0.25% since the insider transaction. Historical insider transactions for DENTSPLY International go as follows:

  • 24-Week # shares sold: 2,840

The average volume for DENTSPLY International has been 795,000 shares per day over the past 30 days. DENTSPLY International has a market cap of $6.8 billion and is part of the health care sector and health services industry. Shares are up 20.15% year to date as of the close of trading on Tuesday.

DENTSPLY International Inc. designs, develops, manufactures, and markets a range of consumable dental products for the professional dental market worldwide. The stock currently has a dividend yield of 0.53%. The company has a P/E ratio of 18.8. Currently there are 4 analysts that rate DENTSPLY International a buy, 1 analyst rates it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on XRAY - FREE

TheStreet Quant Ratings rates DENTSPLY International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year, impressive record of earnings per share growth, compelling growth in net income and notable return on equity. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full DENTSPLY International Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Phillips 66 (PSX) - FREE Research Report

Lowe John E who is Director at Phillips 66 sold 5,000 shares at $65.00 on Nov. 12, 2013. Following this transaction, the Director owned 40,000 shares meaning that the stake was reduced by 11.11% with the 5,000 share transaction.

The shares most recently traded at $65.64, up $0.64, or 0.97% since the insider transaction. Historical insider transactions for Phillips 66 go as follows:

  • 4-Week # shares bought: 7,760
  • 12-Week # shares bought: 7,760
  • 24-Week # shares bought: 7,760
  • 24-Week # shares sold: 5,000

The average volume for Phillips 66 has been 3.4 million shares per day over the past 30 days. Phillips 66 has a market cap of $39.3 billion and is part of the basic materials sector and energy industry. Shares are up 23.33% year to date as of the close of trading on Tuesday.

Phillips 66 operates as an independent downstream energy company. The company operates in three segments: Refining and Marketing (R&M), Midstream, and Chemicals. The stock currently has a dividend yield of 2.38%. The company has a P/E ratio of 11.4. Currently there are 6 analysts that rate Phillips 66 a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PSX - FREE

TheStreet Quant Ratings rates Phillips 66 as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, unimpressive growth in net income and poor profit margins. Get the full Phillips 66 Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Invesco (IVZ) - FREE Research Report

Armour Gregory Mark who is Smd at Invesco sold 50,000 shares at $32.89 on Nov. 12, 2013. Following this transaction, the Smd owned 214,759 shares meaning that the stake was reduced by 18.89% with the 50,000 share transaction.

The shares most recently traded at $32.83, down $0.06, or 0.18% since the insider transaction.

The average volume for Invesco has been 4.0 million shares per day over the past 30 days. Invesco has a market cap of $14.9 billion and is part of the financial sector and financial services industry. Shares are up 28.67% year to date as of the close of trading on Tuesday.

Invesco Ltd. is a publicly owned investment manager. It primarily provides its services to institutional clients including major public entities, corporations, unions, non-profit organizations, endowments, foundations, pension funds, and financial institutions. The stock currently has a dividend yield of 2.68%. The company has a P/E ratio of 18.3. Currently there are 8 analysts that rate Invesco a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on IVZ - FREE

TheStreet Quant Ratings rates Invesco as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, increase in net income, good cash flow from operations and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Invesco Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Purdue Pharma Unloads Sales Staff, Transitioning From Painkiller Focus

Purdue Pharma Unloads Sales Staff, Transitioning From Painkiller Focus